Format

Send to

Choose Destination
Vet Hum Toxicol. 1993 Feb;35(1):45-8.

Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.

Author information

1
Department of Medicine, Michigan State University, East Lansing 48824.

Abstract

We undertook a retrospective review of all the liver biopsies done by us between 1985 and 1990 for the purpose of monitoring methotrexate (MTX)-induced hepatotoxicity in rheumatoid arthritis (RA) patients. A total of 29 biopsies were done in 25 patients. The mean total cumulative dose of MTX was 1585 +/- 348 (SD) mg. Average duration of MTX therapy was 31 +/- 9.8 mo (SD). Liver biopsy after accumulating 900 mg and 1200 mg MTX, respectively, in 2 obese diabetic patients showed evidence of cirrhosis. Obese diabetics may represent a subgroup of RA patients at risk for developing MTX-induced hepatotoxicity.

PMID:
8434456
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center